Hepatitis C is one of the most silent diseases. Viruses that cause disease enter the body through blood contact, enter the blood into the liver and live in the liver in an inactive form for a long time. If left untreated, long enough for the virus to multiply and cause illness, it can lead to cancer or difficult treatment.

The genetic material of the hepatitis C virus is single-stranded RNA. Patients can be tested for hepatitis C for HCV RNA positive about 2 weeks after exposure to the virus, much earlier than testing for anti-HCV antibodies. Quantitative HCV RNA testing by PCR is highly sensitive and can help detect HCV virus even at very low blood levels.

Hepatitis C is a dangerous disease that progresses silently and can cause the patient to face complications such as cirrhosis and liver cancer. The transmission of the hepatitis C virus is mainly due to contact with the blood of an infected person. So can a mother with hepatitis C breastfeed her baby?

Viral hepatitis is one of the most important infectious diseases worldwide as well as in Vietnam. Among them, hepatitis C (also known as HCV) is the leading cause of liver transplants in the United States. Vietnamese people are 3 to 4 times more likely to be hepatitis C positive than other ethnic groups.

Of the five types of hepatitis viruses identified to date, hepatitis C virus, discovered in 1989, is considered particularly dangerous, due to its ability to easily turn into chronic hepatitis, which then progresses to cirrhosis and liver cancer.

Hepatitis C is an infection caused by the hepatitis C virus (HCV). It can be transmitted from person to person through unsafe sex. According to one study, 1 in 190,000 cases of unsafe sex will be infected with the hepatitis C virus.

Hepatitis C is an infectious disease caused by the hepatitis C virus (HCV). The disease often progresses from acute to chronic without showing symptoms. Undiagnosed and untreated chronic hepatitis C increases the risk of cirrhosis, liver failure, and liver cancer.

HCV infection has become a global health problem with an estimated 175 million people chronically infected and more than 4 million new cases each year. Many of those infected are asymptomatic and unaware of the condition. Acute HCV infection may cause few, mild, nonspecific symptoms, and chronic infections may remain dormant for a decade or two before causing enough liver damage to affect liver function. Therefore, the development of the automated HCV Ab immunoassay will screen and help in early diagnosis and timely treatment.

Hepatitis C is one of the leading causes of cirrhosis and liver cancer. The HCV RNA quantitative test helps count the amount of hepatitis C virus that is active in the patient's body, from which treatment or monitoring can be decided.